Advanced Solutions Center (ASCENT) builds unique companies through an evolutionary methodology that create breakthrough technologies․ The innovative approach enables ASCENT to originate and foster the continuous development of science-intensive ventures, that can result in bountiful in aggregate value, thousands of patents and a pipeline to include a multitude of technological development programs․ The second batch of the program focuses on molecular biology, microbiology, biochemistry, biotechnology, computational biology, pharmaceutical, and biomedical sciences.
ASCENT aims to create advanced solutions and eventually spin-off companies. The ASCENT’s scientists explore original scientific hypotheses, conceive and refine unconventional approaches to research problems, discover market niches where technological breakthroughs can take place, and develop revolutionary solutions in the life sciences. Prototypes/solutions are developed resulting in the creation of new companies. The researchers working on a prototype/solution receive equity in the spin-off companies in addition to the competitive salaries offered by ASCENT. A venture capital fund associated with ASCENT will invest in spin-off companies to ensure their growth.